Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Pharmacia and Recordati collaborate on potential overactive bladder treatments

Sep. 1, 2000

Abbott develops potential new compounds for incontinence therapy

Sep. 1, 2000

Fujisawa continues research into treatments for urinary incontinence

Aug. 31, 2000

NexMed presents results of topical alprostadil treatment

Aug. 31, 2000

More potent and selective PDE5 inhibitors developed

Aug. 29, 2000

MCA lifts clinical hold on Vasomax

Aug. 21, 2000

New compounds interacting with muscarinic M3 receptor useful for urinary disorders

Aug. 18, 2000

New series of tricyclic vasopressin agonists under study at AHP

Aug. 17, 2000

U.K. clinical hold on Invicorp removed

Aug. 16, 2000

New selective alpha1A receptor antagonists useful for treatment of BPH

Aug. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...